Table 7

Multivariate model for death within 1 year in patients with AML

VariableHazard ratio95% hazard ratio CIP
Women, vs men 1.0 0.9-1.1 .8 
Catheter, vs no 0.5 0.4-0.5 < .001 
Elixhauser 1, vs 0 1.4 1.2-1.5 < .001 
Elixhauser 2 1.5 1.4-1.7 < .001 
Elixhauser 3 or more 1.7 1.5-1.8 < .001 
VTE, vs no 1.0 0.8-1.2 .99 
Age 25-59 y, vs younger than 25 y 1.9 1.5-2.3 < .001 
Age 60 y or older 4.0 3.3-4.9 < .001 
Black, vs white 1.0 0.9-1.2 .8 
Hispanic 1.0 0.9-1.1 .6 
Asian 0.8 0.7-0.9 .001 
AML NOS, vs M3 1.6 1.3-1.9 < .001 
AML M1/2 1.4 1.1-1.7 .006 
AML M4/5 1.5 1.2-1.8 .001 
VariableHazard ratio95% hazard ratio CIP
Women, vs men 1.0 0.9-1.1 .8 
Catheter, vs no 0.5 0.4-0.5 < .001 
Elixhauser 1, vs 0 1.4 1.2-1.5 < .001 
Elixhauser 2 1.5 1.4-1.7 < .001 
Elixhauser 3 or more 1.7 1.5-1.8 < .001 
VTE, vs no 1.0 0.8-1.2 .99 
Age 25-59 y, vs younger than 25 y 1.9 1.5-2.3 < .001 
Age 60 y or older 4.0 3.3-4.9 < .001 
Black, vs white 1.0 0.9-1.2 .8 
Hispanic 1.0 0.9-1.1 .6 
Asian 0.8 0.7-0.9 .001 
AML NOS, vs M3 1.6 1.3-1.9 < .001 
AML M1/2 1.4 1.1-1.7 .006 
AML M4/5 1.5 1.2-1.8 .001 

Bold entries indicate statistically significant.

Close Modal

or Create an Account

Close Modal
Close Modal